Cargando…
Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma
Accurate risk-stratification can facilitate precision therapy in oropharyngeal squamous cell carcinoma (OPSCC). We explored the potential added value of baseline positron emission tomography (PET)/computed tomography (CT) radiomic features for prognostication and risk stratification of OPSCC beyond...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407414/ https://www.ncbi.nlm.nih.gov/pubmed/32635216 http://dx.doi.org/10.3390/cancers12071778 |
_version_ | 1783567615153668096 |
---|---|
author | Haider, Stefan P. Zeevi, Tal Baumeister, Philipp Reichel, Christoph Sharaf, Kariem Forghani, Reza Kann, Benjamin H. Judson, Benjamin L. Prasad, Manju L. Burtness, Barbara Mahajan, Amit Payabvash, Seyedmehdi |
author_facet | Haider, Stefan P. Zeevi, Tal Baumeister, Philipp Reichel, Christoph Sharaf, Kariem Forghani, Reza Kann, Benjamin H. Judson, Benjamin L. Prasad, Manju L. Burtness, Barbara Mahajan, Amit Payabvash, Seyedmehdi |
author_sort | Haider, Stefan P. |
collection | PubMed |
description | Accurate risk-stratification can facilitate precision therapy in oropharyngeal squamous cell carcinoma (OPSCC). We explored the potential added value of baseline positron emission tomography (PET)/computed tomography (CT) radiomic features for prognostication and risk stratification of OPSCC beyond the American Joint Committee on Cancer (AJCC) 8th edition staging scheme. Using institutional and publicly available datasets, we included OPSCC patients with known human papillomavirus (HPV) status, without baseline distant metastasis and treated with curative intent. We extracted 1037 PET and 1037 CT radiomic features quantifying lesion shape, imaging intensity, and texture patterns from primary tumors and metastatic cervical lymph nodes. Utilizing random forest algorithms, we devised novel machine-learning models for OPSCC progression-free survival (PFS) and overall survival (OS) using “radiomics” features, “AJCC” variables, and the “combined” set as input. We designed both single- (PET or CT) and combined-modality (PET/CT) models. Harrell’s C-index quantified survival model performance; risk stratification was evaluated in Kaplan–Meier analysis. A total of 311 patients were included. In HPV-associated OPSCC, the best “radiomics” model achieved an average C-index ± standard deviation of 0.62 ± 0.05 (p = 0.02) for PFS prediction, compared to 0.54 ± 0.06 (p = 0.32) utilizing “AJCC” variables. Radiomics-based risk-stratification of HPV-associated OPSCC was significant for PFS and OS. Similar trends were observed in HPV-negative OPSCC. In conclusion, radiomics imaging features extracted from pre-treatment PET/CT may provide complimentary information to the current AJCC staging scheme for survival prognostication and risk-stratification of HPV-associated OPSCC. |
format | Online Article Text |
id | pubmed-7407414 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74074142020-08-25 Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma Haider, Stefan P. Zeevi, Tal Baumeister, Philipp Reichel, Christoph Sharaf, Kariem Forghani, Reza Kann, Benjamin H. Judson, Benjamin L. Prasad, Manju L. Burtness, Barbara Mahajan, Amit Payabvash, Seyedmehdi Cancers (Basel) Article Accurate risk-stratification can facilitate precision therapy in oropharyngeal squamous cell carcinoma (OPSCC). We explored the potential added value of baseline positron emission tomography (PET)/computed tomography (CT) radiomic features for prognostication and risk stratification of OPSCC beyond the American Joint Committee on Cancer (AJCC) 8th edition staging scheme. Using institutional and publicly available datasets, we included OPSCC patients with known human papillomavirus (HPV) status, without baseline distant metastasis and treated with curative intent. We extracted 1037 PET and 1037 CT radiomic features quantifying lesion shape, imaging intensity, and texture patterns from primary tumors and metastatic cervical lymph nodes. Utilizing random forest algorithms, we devised novel machine-learning models for OPSCC progression-free survival (PFS) and overall survival (OS) using “radiomics” features, “AJCC” variables, and the “combined” set as input. We designed both single- (PET or CT) and combined-modality (PET/CT) models. Harrell’s C-index quantified survival model performance; risk stratification was evaluated in Kaplan–Meier analysis. A total of 311 patients were included. In HPV-associated OPSCC, the best “radiomics” model achieved an average C-index ± standard deviation of 0.62 ± 0.05 (p = 0.02) for PFS prediction, compared to 0.54 ± 0.06 (p = 0.32) utilizing “AJCC” variables. Radiomics-based risk-stratification of HPV-associated OPSCC was significant for PFS and OS. Similar trends were observed in HPV-negative OPSCC. In conclusion, radiomics imaging features extracted from pre-treatment PET/CT may provide complimentary information to the current AJCC staging scheme for survival prognostication and risk-stratification of HPV-associated OPSCC. MDPI 2020-07-03 /pmc/articles/PMC7407414/ /pubmed/32635216 http://dx.doi.org/10.3390/cancers12071778 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Haider, Stefan P. Zeevi, Tal Baumeister, Philipp Reichel, Christoph Sharaf, Kariem Forghani, Reza Kann, Benjamin H. Judson, Benjamin L. Prasad, Manju L. Burtness, Barbara Mahajan, Amit Payabvash, Seyedmehdi Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma |
title | Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma |
title_full | Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma |
title_fullStr | Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma |
title_full_unstemmed | Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma |
title_short | Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma |
title_sort | potential added value of pet/ct radiomics for survival prognostication beyond ajcc 8th edition staging in oropharyngeal squamous cell carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407414/ https://www.ncbi.nlm.nih.gov/pubmed/32635216 http://dx.doi.org/10.3390/cancers12071778 |
work_keys_str_mv | AT haiderstefanp potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT zeevital potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT baumeisterphilipp potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT reichelchristoph potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT sharafkariem potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT forghanireza potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT kannbenjaminh potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT judsonbenjaminl potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT prasadmanjul potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT burtnessbarbara potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT mahajanamit potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma AT payabvashseyedmehdi potentialaddedvalueofpetctradiomicsforsurvivalprognosticationbeyondajcc8theditionstaginginoropharyngealsquamouscellcarcinoma |